Idexx Laboratories Overview

  • Year Founded
  • 1983

Year Founded

  • Status
  • Public

  • Employees
  • 11,000

Employees

  • Stock Symbol
  • IDXX

Stock Symbol

  • Investments
  • 32

  • Share Price
  • $491.48
  • (As of Monday Closing)

Idexx Laboratories General Information

Description

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

Contact Information

Website
www.idexx.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare
Other Devices and Supplies
Stock Exchange
NAS
Corporate Office
  • One Idexx Drive
  • Westbrook, ME 04092
  • United States
+1 (207) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Idexx Laboratories Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$491.48 $495.73 $372.50 - $583.39 $40.6B 82.6M 504K $10.43

Idexx Laboratories Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 45,456,831 46,906,316 35,192,924 56,651,875
Revenue 3,724,853 3,660,953 3,367,324 3,215,360
EBITDA 1,232,168 1,212,036 1,010,665 1,036,624
Net Income 866,567 845,042 679,089 744,845
Total Assets 3,353,515 3,259,925 2,746,765 2,437,203
Total Debt 1,068,942 1,067,353 1,470,033 1,031,009
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Idexx Laboratories Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Idexx Laboratories‘s full profile, request access.

Request a free trial

Idexx Laboratories Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pe
Diagnostic Equipment
Westbrook, ME
11,000 As of 2023
00.00
000000000000 00.00

000000

im veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commo
0000000000 000000000
Waltham, MA
00000 As of 0000
00.000
000000000 00.000

00000

ing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
0000000000 000000000
Loveland, CO
000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Idexx Laboratories Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Revvity Corporation Waltham, MA 00000 00.000 000000000 00.000
Heska Private Equity-Backed Loveland, CO 000 00.000 000000000 00.000
KARL STORZ Corporation Tuttlingen, Germany 0000
Mindray Formerly VC-backed Shenzhen, China 00000 00000 0000 00000
Samsung Electronics Corporation Suwon-si, South Korea 000000 0000
To view Idexx Laboratories’s complete competitors history, request access »

Idexx Laboratories Patents

Idexx Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240179021-A1 Methods and systems for enabling electronic access to medical record information of a veterinary patient over a network Pending 30-Nov-2022 00000000
US-20240177849-A1 Automated calibration method and system for a diagnostic analyzer Pending 29-Nov-2022 000000000
CA-3221332-A1 Automated calibration method and system for a diagnostic analyzer Pending 29-Nov-2022 000000000
US-20240151734-A1 Systems and methods for identifying blood conditions via dot plot analysis Pending 07-Nov-2022 000000000
US-20240153633-A1 Clinical diagnostic and patient information systems and methods Pending 03-Nov-2022 G16H50/20
To view Idexx Laboratories’s complete patent history, request access »

Idexx Laboratories Executive Team (39)

Name Title Board Seat Contact Info
Jonathan Mazelsky President, Chief Executive Officer and Board Member
Brian Mckeon Executive Vice President, Chief Financial Officer and Treasurer
Martin Smith Chief Technology Officer, Technology & Executive Vice President
Don Schofield Director & General Manager
Mike Erickson Ph.D Executive Vice President and General Manager of Point of Care Diagnostics and Telemedicine
You’re viewing 5 of 39 executive team members. Get the full list »

Idexx Laboratories Board Members (17)

Name Representing Role Since
Asha Collins Idexx Laboratories Board Member 000 0000
Bruce Claflin Idexx Laboratories Board Member 000 0000
Daniel Junius Self Board Member 000 0000
Irene Chang Britt Self Board Member 000 0000
Jonathan Ayers Idexx Laboratories Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

Idexx Laboratories Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Idexx Laboratories Investments & Acquisitions (32)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
TECTA-PDS 25-Aug-2022 0000000000 Environmental Services (B2B) 0000-0000
Epocal 12-Jan-2022 0000000000 Monitoring Equipment
IDEXX Laboratories (Reference Laboratory) 01-Dec-2021 000000000 000.00 Buildings and Property
EzyVet 02-Jun-2021 0000000000 00000 Business/Productivity Software
Vet Radar 02-Jun-2021 Merger/Acquisition Enterprise Systems (Healthcare)
You’re viewing 5 of 32 investments and acquisitions. Get the full list »

Idexx Laboratories Subsidiaries (12)

Company Name Industry Location Founded
Vet Radar Enterprise Systems (Healthcare) Auckland, New Zealand 2018
Smart Flow (Enterprise Systems (Healthcare)) Enterprise Systems (Healthcare) Etobicoke, Canada 0000
EzyVet Business/Productivity Software Frisco, TX 0000
Petly Health Plan Management Other Healthcare Technology Systems Brandon, FL 0000
DVMInsight Application Software San Diego, CA 0000
You’re viewing 5 of 12 subsidiaries. Get the full list »

Idexx Laboratories ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

16.32 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,191

Rank

00.00

Percentile

Healthcare

Industry

00 of 643

Rank

00.00

Percentile

Medical Devices

Subindustry

0. of 229

Rank

0.00

Percentile

To view Idexx Laboratories’s complete esg history, request access »

Idexx Laboratories Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
Acumedia Manufacturers 30-Jan-1997 000000000000000000 00.000 Completed
  • 00000 000000000000
Purisys 22-Aug-1994 Secondary Transaction - Private 00000 Completed
To view Idexx Laboratories’s complete exits history, request access »

Idexx Laboratories FAQs

  • When was Idexx Laboratories founded?

    Idexx Laboratories was founded in 1983.

  • Who is the CEO of Idexx Laboratories?

    Jonathan Mazelsky is the CEO of Idexx Laboratories.

  • Where is Idexx Laboratories headquartered?

    Idexx Laboratories is headquartered in Westbrook, ME.

  • What is the size of Idexx Laboratories?

    Idexx Laboratories has 11,000 total employees.

  • What industry is Idexx Laboratories in?

    Idexx Laboratories’s primary industry is Diagnostic Equipment.

  • Is Idexx Laboratories a private or public company?

    Idexx Laboratories is a Public company.

  • What is Idexx Laboratories’s stock symbol?

    The ticker symbol for Idexx Laboratories is IDXX.

  • What is the current stock price of Idexx Laboratories?

    As of 24-Jun-2024 the stock price of Idexx Laboratories is $491.48.

  • What is the current market cap of Idexx Laboratories?

    The current market capitalization of Idexx Laboratories is $40.6B.

  • What is Idexx Laboratories’s current revenue?

    The trailing twelve month revenue for Idexx Laboratories is $3.72B.

  • Who are Idexx Laboratories’s competitors?

    Revvity, Heska, KARL STORZ, Mindray, and Samsung Electronics are some of the 6 competitors of Idexx Laboratories.

  • What is Idexx Laboratories’s annual earnings per share (EPS)?

    Idexx Laboratories’s EPS for 12 months was $10.43.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »